The first children have received the RTS,S/AS01 (RTS,S) malaria vaccine through routine immunization in Malawi, marking the beginning of a pilot introduction of the vaccine. Read more......
-
MVI Portfolio
We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. -
Evaluation technology projects
We partner to develop and optimize new assays and challenge models and support reference and service laboratories. -
RTS,S
RTS,S/AS01 (RTS,S) is the world’s first malaria vaccine shown to provide partial protection against malaria in young children.
